Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]…

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, August 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,876 followers.

Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen… https://t.co/HcdfUydhY7 #liversurgery

Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen… https://t.co/hygX9esdz8 #breastcancer